Brandon Capital is an institutional investor (Healthcare Startups) founded in 2007 and headquartered in San Francisco, United States. Provider of seed and venture capital for life science companies. It supports companies from proof-of-concept to commercialization, partnering with entrepreneurs for long-term growth. Investments focus on developing medical innovations, aiming for strong financial returns and improved patient outcomes. The firm offers co-investment arrangements, expanding its capacity to support portfolio companies. It invests early, often serving as the founding investor.

Stage

seed, early-stage venture, Series A, Series B, growth, expansion capital, late-stage, seed, early-stage venture, Series A, Series B, growth, expansion capital, late-stage

Check size

AU$500K - AU$30M (often $10M-$50M in larger rounds)

HQ

Melbourne, Australia

Founded

2007

Website

https://brandoncapital.vc

LinkedIn

https://linkedin.com/company/brandon-capital

What they look for

Associated with member research institutes via Brandon BioCatalyst (primarily Australia/NZ), promising biomedical innovations from proof-of-concept to late-stage with strong commercial potential; invests in ANZ startups and international scale-ups (US, UK, Europe); prefers science-driven opportunities in life sciences

Preparing to pitch Brandon Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.